Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre”…
Demand AI Group Secures $2.5 Million in Funding from International Institutional and Local Investors
DENVER, Sept. 12, 2025 /PRNewswire/ -- Demand AI Group Inc. ("Demand AI"),…
